The involvement of MAPK and PI3K/AKT pathways has been reported as one of the major routes through which Mel exerts these anti-migratory effects in different cancer models, including ovarian, breast, and colon cancers [44], [45], [42]. The gene discussed is AKT1; the disease is cancer.